Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Forty Seven raises first half of $75mm Series A round; closes round

Executive Summary

Stanford University spin-out Forty Seven Inc. raised the first half of a committed $75mm Series A round to fund its development work in immuno-oncology. Co-leads Lightspeed Venture Partners and Sutter Hill Ventures were joined by Clarus Ventures and GV (formerly Google Ventures) in the financing.

Deal Industry
  • Pharmaceuticals
  • Biotechnology
    • Large Molecule
      • Antibodies
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies